Novartis India Share Price in 2007: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2007?

Let's find out!

Novartis India share price in 2007 was ₹416.4 Its price on 1st January 2007 was ₹356, and by 31st December 2007 it moved to ₹416.4, giving a positive return of 16.96% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2007 are as follows:

Open	High	Low	Close
₹356	₹439.9	₹269	₹416.4
1st Jan 2007	Occured in Dec 2007	Occured in Aug 2007	31st Dec 2007

This page will help you understand how Novartis India performed in 2007. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2007

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹357	-	↑ ₹431 ↓ ₹352.5
Feb	₹338.15	-5.3%	↑ ₹365 ↓ ₹330.1
Mar	₹313.64	-7.3%	↑ ₹373.85 ↓ ₹307.3
Apr	₹329	4.8%	↑ ₹345 ↓ ₹310.14
May	₹360.85	9.6%	↑ ₹383.4 ↓ ₹306
Jun	₹380.85	5.5%	↑ ₹417.7 ↓ ₹342.3
Jul	₹342.55	-10.1%	↑ ₹389.85 ↓ ₹331
Aug	₹292	-14.8%	↑ ₹345.85 ↓ ₹269
Sep	₹323.7	10.8%	↑ ₹327 ↓ ₹287.14
Oct	₹318.35	-1.7%	↑ ₹360.45 ↓ ₹279.2
Nov	₹330.2	3.7%	↑ ₹370 ↓ ₹307.05
Dec	₹416.4	26.1%	↑ ₹439.9 ↓ ₹328.25

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2007?

In 2007, the opening price of Novartis India share was ₹356.00. Today, the price stands at ₹672.25, reflecting a growth of 88.83%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2007 would have become ₹18,883.42 by 2025. This represents a CAGR of 3.59%.

---

You might also like to check: Novartis India Stock Price in 2006 or Novartis India Stock Price in 2008

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.